Greta Pettenuzzo

ORCID: 0009-0008-3256-4624
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bladder and Urothelial Cancer Treatments
  • Renal cell carcinoma treatment
  • Surgical Simulation and Training
  • Minimally Invasive Surgical Techniques
  • Urinary and Genital Oncology Studies
  • Pituitary Gland Disorders and Treatments
  • Renal and related cancers
  • Vascular Malformations and Hemangiomas
  • Lymphatic Disorders and Treatments
  • Multiple and Secondary Primary Cancers
  • Hormonal Regulation and Hypertension
  • Gastrointestinal disorders and treatments
  • Adrenal and Paraganglionic Tumors
  • Esophageal Cancer Research and Treatment
  • Urological Disorders and Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Organ Donation and Transplantation

University of Illinois Chicago
2025

Azienda Ospedaliera Universitaria Integrata Verona
2023-2025

University of Verona
2023-2025

Provincia Autonoma di Trento
2024

Background: The Da Vinci single-port (SP) platform is being used more frequently in radical prostatectomy (RP). In this study we aimed to compare the complications and oncological outcomes of SP robotic-assisted (SP-RARP) between elderly young age-groups further examine differences young-old old-old patients. Materials Methods: Data from 193 patients who underwent SP-RARP December 2018 June 2024 were analyzed. Patients categorized into two age-groups: (18-64 years) (65+ years). group was...

10.1089/lap.2024.0387 article EN Journal of Laparoendoscopic & Advanced Surgical Techniques 2025-01-29

Introduction: Adrenalectomies are widely regarded as the preferred treatment for adrenal tumors, typically conducted via laparoscopic or robotic transperitoneal approaches.1 In contrast, posterior retroperitoneal approaches less common, largely due to constrained maneuvering space they offer. Single-port radical adrenalectomy (SP-RRA) has become increasingly popular possibility combine several advantages, such reduced postoperative pain, shorter operative durations, decreased blood loss, and...

10.1089/vid.2024.0036 article EN Videourology 2025-01-01

The aim of this study was to explore perioperative and functional outcomes in a cohort patients with highly hostile abdomens treated retroperitoneal (RP) single port vs transperitoneal multiport robot assisted partial nephrectomy. Clinical surgical data all consecutive RP single-port nephrectomy between March 2019 January 2024 were prospectively collected retrospectively analyzed. presence "hostile abdomen" defined as personal history at least one major abdominal surgery. Multivariable...

10.23736/s2724-6051.25.06245-7 article EN Minerva Urology and Nephrology 2025-04-01

Chyluria, an abnormal lymphatic disorder, results in excessive abdominal lymph drainage into the urinary system, causing protein loss, nutritional deficiencies, and immune issues. Mainly linked to parasitic infections developed countries, non-parasitic causes like trauma or tumors are rare. Typically appearing adults with bilateral involvement, management options include conservative surgical approaches. We present case of a 13-year-old congenital chyluria, treated robot-assisted staged...

10.1016/j.eucr.2024.102720 article EN cc-by-nc-nd Urology Case Reports 2024-03-25

You have accessJournal of UrologyBladder Cancer: Upper Tract Transitional Cell Carcinoma II (MP38)1 May 2024MP38-18 DECISIONAL AND PROGNOSTIC IMPACT OF DIAGNOSTIC URETEROSCOPY IN HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA: A MULTI-INSTITUTIONAL COLLABORATIVE ANALYSIS (ROBUUST GROUP) Francesco Ditonno, Alessandro Veccia, Greta Pettenuzzo, Francesca Montanaro, Sonia Costantino, Antonio Franco, Firas Abdollah, Marco Finati, Giuseppe Simone, Gabriele Tuderti, Emma Helstrom, Andreas Correa,...

10.1097/01.ju.0001008700.92603.b1.18 article EN The Journal of Urology 2024-04-15

To assess whether tumor location at diagnostic TURBT is predictive of ipsilateral nodal involvement in patients who underwent radical cystectomy (RC) with lymph-nodes dissection for bladder cancer (BCa).

10.1016/j.urolonc.2024.09.037 article EN cc-by Urologic Oncology Seminars and Original Investigations 2024-10-01
Coming Soon ...